Log in to save to my catalogue

A novel retinoic acid receptor-γ agonist antagonizes immune checkpoint resistance in lung cancers by...

A novel retinoic acid receptor-γ agonist antagonizes immune checkpoint resistance in lung cancers by...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_3a6d32daebaf4a6c91b60abe62aa93bd

A novel retinoic acid receptor-γ agonist antagonizes immune checkpoint resistance in lung cancers by altering the tumor immune microenvironment

About this item

Full title

A novel retinoic acid receptor-γ agonist antagonizes immune checkpoint resistance in lung cancers by altering the tumor immune microenvironment

Publisher

London: Nature Publishing Group UK

Journal title

Scientific reports, 2023-09, Vol.13 (1), p.14907-14907, Article 14907

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

All-
trans
-retinoic acid (ATRA), the retinoic acid receptors (RARs) agonist, regulates cell growth, differentiation, immunity, and survival. We report that ATRA-treatment repressed cancer growth in syngeneic immunocompetent, but not immunodeficient mice. The tumor microenvironment was implicated: CD8
+
 T cell depletion antagonized ATR...

Alternative Titles

Full title

A novel retinoic acid receptor-γ agonist antagonizes immune checkpoint resistance in lung cancers by altering the tumor immune microenvironment

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_3a6d32daebaf4a6c91b60abe62aa93bd

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_3a6d32daebaf4a6c91b60abe62aa93bd

Other Identifiers

ISSN

2045-2322

E-ISSN

2045-2322

DOI

10.1038/s41598-023-41690-5

How to access this item